Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was more efficacious in reducing deaths in high-risk individuals than conventional radiography. As such, an ever-increasing number of health organizations now recommend this screening protocol.Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues, fulfills the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking. Subsequent chapters cover the fundamentals, with clinical pearls on setting up a successful lung cancer screening program, patient eligibility criteria, imaging variances of tumors in the lungs, screening pros and cons, and interpreting/reporting screening results. - The evolution and future of lung cancer screenings Detection and management of unexpected incidental pulmonary and nonpulmonary findings Discussion of test cases utilizing the LungRADSTM riskstratifying system for lowdose chest CT screenings Benefits and potential harms associated with mass lung cancer screening programs including false positive, false negative, and overdiagnosis rates This stateoftheart guide is essential reading for radiologists, oncologists, pulmonologists, and internists. It is a musthave bookshelf reference for hospital radiology and oncology departments, in particular for those setting up new lung cancer screening programs.

Hersteller:
Thieme Medical Publishers
customerservice@thieme.com
333 Seventh Avenue, 18th Floor
US 10001 New York
Importeur:
Georg Thieme Verlag KG
info@thieme.de
Oswald-Hesse-Straße 50
DE 70469 Stuttgart